Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression

The ability to predict the trajectory of disease progression with high resolution for individual patients can enhance clinical trial design, enabling personalized, data-driven medical approaches. In this study, we deployed a kernel/Gaussian process-based dynamic model to predict Alzheimer's disease progression. Our numerical results demonstrate that the dynamic method outperforms static linear regression, improving the prediction of ADAS-Cog 11 subscores over extended periods by effectively incorporating intermediate data observations. This approach highlights the potential of computational models in enhancing clinical trial design and advancing personalized medicine for Alzheimer's disease.

Authors

Institutions

Publication Details

Journal
Journal of Alzheimer s Disease
Published
2025-12-12
DOI
https://doi.org/10.1177/13872877251404082
Primary Topic
Gaussian Processes and Bayesian Inference
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression

Matthew H. Levine, Matthieu Darcy, Yi Zhang, Houman Owhadi et al.
Journal of Alzheimer s Disease
Gaussian Processes and Bayesian Inference
article

Benchmarking Gaussian processes for prediction and data assimilation of Alzheimer's disease progression

Matthew H. Levine, Matthieu Darcy, Yi Zhang, Houman Owhadi, Khaled Sarsour, Mehrad Bastani, Pau Batlle, Francisco Talamas
article en

Abstract

The ability to predict the trajectory of disease progression with high resolution for individual patients can enhance clinical trial design, enabling personalized, data-driven medical approaches. In this study, we deployed a kernel/Gaussian process-based dynamic model to predict Alzheimer's disease progression. Our numerical results demonstrate that the dynamic method outperforms static linear regression, improving the prediction of ADAS-Cog 11 subscores over extended periods by effectively incorporating intermediate data observations. This approach highlights the potential of computational models in enhancing clinical trial design and advancing personalized medicine for Alzheimer's disease.

Journal of Alzheimer s DiseaseVol. 109(3)
Broad Institute (US), California Institute of Technology (US), Johnson & Johnson (United States) (US), Emergency University (US), The Alan Turing Institute (GB)
Openalex Percentile: Top 79%
Gaussian Processes and Bayesian Inference
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.